BAFF antagonism with belimumab has proven to be efficacious in systemic lupus erythematosus (SLE), including lupus nephritis [7, 8], and is undergoing evaluation in other autoimmune diseases. The gene discussed is TNFSF13B; the disease is systemic lupus erythematosus.